Arthriten Tablet, Film Coated
NDC Package 52389-237-28

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Arthriten (acetaminophen, aspirin, caffeine) tablets is uses For the temporary relief of minor aches and pains including the minor pain of arthritis. This formulation utilizes a tablet, film coated delivery system. Marketed by Kobayashi Healthcare International, Inc, this product is identified by NDC 52389-237 and is authorized under FDA application M013.

Identification & Billing

NDC Package Code
52389-237-28
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (52389-237-01)
Product Code
52389-237
11-Digit Billing Format
52389023728
RxNorm Crosswalk
  • RxCUI: 1303159 - ARTHRITEN Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet
  • RxCUI: 1303159 - acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]
  • RxCUI: 1303159 - APAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]
  • RxCUI: 1303159 - Arthriten Inflammatory Pain (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet
  • RxCUI: 308297 - acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet

Clinical Specifications

Proprietary Name
Arthriten Inflammatory Pain Formula
Non-Proprietary Name
Acetaminophen, Aspirin, Caffeine
Substance Name
Acetaminophen; Aspirin; Caffeine
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Uses For the temporary relief of minor aches and pains including the minor pain of arthritis.

Regulatory & Marketing

Labeler Name
Kobayashi Healthcare International, Inc
Product Type
Human Otc Drug
FDA Application #
M013
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-23-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52389-237-28 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 28 tablet, film coated in 1 bottle, plastic (52389-237-01) of Arthriten Inflammatory Pain Formula, a human over the counter drug labeled by Kobayashi Healthcare International, Inc. This tablet, film coated is formulated for oral use and contains acetaminophen; aspirin; caffeine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kobayashi Healthcare International, Inc on July 23, 2012. The current certification is valid through December 31, 2026.

How is this Kobayashi Healthcare International, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52389023728. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52389-237-28
11-Digit CMS (5-4-2)
52389-0237-28

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.